SCHEPIS, Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.749
AS - Asia 7.355
EU - Europa 6.070
SA - Sud America 1.161
Continente sconosciuto - Info sul continente non disponibili 264
AF - Africa 194
OC - Oceania 42
Totale 29.835
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.407
SG - Singapore 2.155
CN - Cina 2.007
GB - Regno Unito 1.635
IT - Italia 1.486
BR - Brasile 872
VN - Vietnam 772
HK - Hong Kong 753
DE - Germania 721
BD - Bangladesh 537
SE - Svezia 480
FI - Finlandia 446
RU - Federazione Russa 302
KR - Corea 250
FR - Francia 231
UA - Ucraina 194
TR - Turchia 167
CA - Canada 156
IN - India 142
ID - Indonesia 141
AR - Argentina 102
BG - Bulgaria 93
MX - Messico 92
NL - Olanda 79
ES - Italia 77
JP - Giappone 66
PL - Polonia 54
ZA - Sudafrica 50
AE - Emirati Arabi Uniti 49
CO - Colombia 44
IQ - Iraq 44
BE - Belgio 41
PK - Pakistan 37
EC - Ecuador 35
AU - Australia 34
LT - Lituania 34
AT - Austria 32
MA - Marocco 32
CL - Cile 29
EG - Egitto 27
VE - Venezuela 24
RO - Romania 22
UZ - Uzbekistan 22
MY - Malesia 21
PH - Filippine 21
SA - Arabia Saudita 19
CZ - Repubblica Ceca 18
KE - Kenya 18
PY - Paraguay 18
CR - Costa Rica 17
PE - Perù 17
DZ - Algeria 15
JM - Giamaica 15
NP - Nepal 15
IE - Irlanda 14
TH - Thailandia 14
TN - Tunisia 14
SC - Seychelles 13
HN - Honduras 12
IL - Israele 12
SK - Slovacchia (Repubblica Slovacca) 12
AZ - Azerbaigian 11
DK - Danimarca 11
AL - Albania 10
BH - Bahrain 10
CH - Svizzera 10
KZ - Kazakistan 10
PT - Portogallo 10
UY - Uruguay 10
BO - Bolivia 9
BY - Bielorussia 9
GT - Guatemala 9
NI - Nicaragua 9
DO - Repubblica Dominicana 7
GE - Georgia 7
JO - Giordania 7
LB - Libano 7
EU - Europa 6
GR - Grecia 6
IR - Iran 6
KG - Kirghizistan 6
LV - Lettonia 6
PA - Panama 6
RS - Serbia 6
CY - Cipro 5
HR - Croazia 5
HU - Ungheria 5
PR - Porto Rico 5
QA - Qatar 5
SI - Slovenia 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BZ - Belize 4
EE - Estonia 4
KH - Cambogia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SN - Senegal 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
Totale 29.517
Salva come PNG Salva come JPEG
Città #
Ashburn 1.497
Santa Clara 1.430
Singapore 1.272
Fairfield 1.219
Southend 972
Hong Kong 726
Woodbridge 725
Hefei 707
Chandler 590
Houston 581
San Jose 532
Seattle 495
London 428
Cambridge 418
Wilmington 417
Council Bluffs 376
Helsinki 376
Modena 329
Ann Arbor 327
Nyköping 316
Jacksonville 313
Beijing 282
New York 269
Los Angeles 267
Dearborn 255
Ho Chi Minh City 250
Dallas 248
The Dalles 244
Seoul 234
Berlin 217
Hanoi 190
Sunnyvale 186
Chicago 183
Boardman 123
Milan 122
San Diego 120
Lauterbourg 102
Princeton 95
Jakarta 92
Buffalo 89
Sofia 89
Moscow 79
Shanghai 78
São Paulo 78
Bologna 75
Izmir 75
Frankfurt am Main 74
Rome 68
Munich 62
Salt Lake City 62
Columbus 56
Eugene 56
Orem 55
Tokyo 53
Phoenix 52
Redwood City 50
Atlanta 41
Brooklyn 39
Grafing 39
Da Nang 38
Kent 38
Yalova 38
Tampa 37
Des Moines 35
Nuremberg 35
Warsaw 35
Elk Grove Village 34
Nanjing 34
Naples 34
Guangzhou 33
Rio de Janeiro 32
Brussels 31
Montreal 31
Toronto 31
Redondo Beach 29
Mexico City 28
Haiphong 27
Jersey City 27
Bremen 26
Boston 24
Chennai 24
Johannesburg 24
Mumbai 24
Turku 24
Florence 23
Vancouver 23
Falls Church 22
Denver 21
Stockholm 21
Brasília 20
Melbourne 20
Portsmouth 20
Tashkent 20
Manchester 19
Amsterdam 18
Charlotte 18
Miano 18
Wuhan 18
Dubai 17
North Bergen 17
Totale 19.883
Salva come PNG Salva come JPEG
Nome #
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease 711
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 505
Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis 502
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 496
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 465
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 448
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 446
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 437
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis 429
Baveno VII – Renewing consensus in portal hypertension 412
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 403
PROGRESSIVE ALTERATIONS IN SYSTEMIC AND CARDIOPULMONARY HEMODYNAMICS OCCUR IN PATIENTS WITH CIRRHOSIS AND PREDICT DEATH IN DECOMPENSATED CIRRHOSIS 389
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 384
A new device for ultrasound-guided peripheral venous access 358
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis 356
JLB: a flexible and effective device in critical patients. Review of clinical cases 346
30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice 339
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. 334
Guide-wire replacement of a mini-midline catheter with a central venous catheter: A retrospective study on 63 cases 331
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 324
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 320
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study 312
Consensus conference on TIPS management: Techniques, indications, contraindications 312
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 312
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients 309
Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis 302
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 300
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection 297
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: A case-control study 295
Obese zebrafish: A small fish for a major human health condition 295
Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials 293
Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis 293
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 289
Ccdc80-l1 Is involved in axon pathfinding of zebrafish motoneurons. 289
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 284
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 283
LOW MOLECULAR WEIGHT HEPARIN TREATMENT DOES NOT INCREASE THE RISK OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL BAND LIGATION IN PATIENTS WITH CIRRHOSIS 283
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells. 279
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 275
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. 267
A RANDOMIZED TRIAL OF THE SAFETY AND HEPATIC HEMODYNAMIC EFFECTS OF INTRAVENOUS CONIVAPTAN IN EUVOLEMIC OR HYPERVOLEMIC CIRRHOTIC PATIENTS 266
Chemoprevention of hepatocellular carcinoma 258
Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives 255
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1 255
Natural history of chronic HBV in northern Italy: Morbidity and morality after 30 years 253
The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. 252
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 247
Protection of human endothelial cells from oxidative stress: Role of Ras-ERK1/2 signaling 245
PROCALCITONIN IS THE BEST DIAGNOSTIC AND PROGNOSTIC MARKER OF SEPSIS IN DECOMPENSATED CIRRHOTIC PATIENTS 244
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 243
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 243
Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects. 242
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? 239
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives 238
When and how to treat acute hepatitis C? 237
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis 236
The Coiled-Coil Domain Containing 80 (ccdc80) gene regulates gadd45β2 expression in the developing somites of zebrafish as a new player of the hedgehog pathway 234
Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure 231
Reply to: “Relationship of hyperdynamic circulation and cardiodynamic states in cirrhosis” 230
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. 230
Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. 229
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease 228
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 226
Thrombophilic genetic risk factors for liver fibrosis: To screen or not to screen? 225
Relevance of spontaneous portosystemic shunts detected with CT in patients with cirrhosis 224
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF) 223
Paradoxical embolization in TIPS: take a closer look to the heart 222
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 221
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 221
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. 219
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 212
The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions 206
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives 206
Transjugular intrahepatic portosystemic shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: a real-life, case-control study 201
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 201
Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis 200
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 197
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 193
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 192
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus 191
Pathophysiology of portal hypertension and variceal bleeding 187
Physical activity in liver transplant recipients: a large multicenter study 184
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease 180
Transient elastography and ultrasonography: Optimal evaluation of liver fibrosis and cirrhosis in patients with chronic hepatitis B concurrent with nonalcoholic fatty liver disease 179
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 177
Akt1/Akt2 inhibition and development of hepatocellular carcinoma 177
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation 176
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 174
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS 172
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome 169
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease 167
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome 167
Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex 166
Meta-analysis of Transarterial Embolization in Patients with Unresectable Hepatocellular Carcinoma: Dr Camma and colleagues respond 164
The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment 163
Monitoring Treatment of Cirrhosis and Portal Hypertension 163
Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974, (S0168827821022996), (10.1016/j.jhep.2021.12.022)] 161
Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension 161
Reply to: “It takes two “eyes” to see in depth” 159
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 156
Totale 26.821
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.612
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.574 0 0 157 66 76 111 132 154 208 144 315 211
2022/20231.721 214 206 139 163 151 258 21 174 178 29 125 63
2023/20241.153 50 62 78 118 183 90 152 113 62 21 88 136
2024/20255.239 135 63 66 336 983 742 344 390 764 306 520 590
2025/202611.479 761 570 1.067 1.190 1.250 923 1.218 574 1.039 1.170 835 882
2026/20271.461 417 1.028 16 0 0 0 0 0 0 0 0 0
Totale 29.835